ACTEMRA 200 MG_10 ML IV INFUZYONLUK COZELTI

1. With an aim to become a leading entity in this field, we are engaged in offering top - notch grade ACTEMRA 200 MG_10 ML IV INFUZYONLUK COZELTI.

2. Backed with immense knowledge in this field, we are engaged in offering superior grade ACTEMRA 200 MG_10 ML IV INFUZYONLUK COZELTI in moisture proof packaging options.

• Active tuberculosis, which may present with pulmonary or extrapulmonary disease. Patients should be tested for latent tuberculosis before ACTEMRA use and during therapy. Treatment for latent infection should be initiated prior to ACTEMRA use.
• Invasive fungal infections, including candidiasis, aspergillosis, and pneumocystis. Patients with invasive fungal infections may present with disseminated, rather than localized, disease.
• Bacterial, viral and other infections due to opportunistic pathogens.